FDA Approves Early Human Trial of Potential HIV Functional Cure

As taken from POZ on-line 3/2015

The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy that may lead to a functional cure, Medical Daily reports. The treatment involves drawing blood-producing stem cells from HIV-positive study participants who have had a poor response to antiretroviral (ARV) therapy. Next, the researchers will splice in genetic instructions to immune cells to make them resistant to the virus.

Read more:  http://www.poz.com/articles/functional_cure_trial_761_26943.shtml